Bolt Biotherapeutics, Inc. BOLT Q2 2026 earnings

FAQ

When did Bolt Biotherapeutics, Inc. report Q2 2026 earnings?

Bolt Biotherapeutics, Inc. (BOLT) reported Q2 2026 earnings on August 11, 2026 after market close.

What were Bolt Biotherapeutics, Inc.'s Q2 2026 revenue and EPS?

Bolt Biotherapeutics, Inc. reported revenue of $5.0K and eps of $-4.57 for Q2 2026.

Did Bolt Biotherapeutics, Inc. beat estimates in Q2 2026?

Revenue missed the consensus estimate of $500.0K by $495.0K. EPS missed the consensus estimate of $-3.39 by $1.18.

How did Bolt Biotherapeutics, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 99.7% from $1.8M a year earlier and eps declined 2.5% from $-4.46.

Where can I find Bolt Biotherapeutics, Inc.'s Q2 2026 SEC filings?

You can read the 8-K earnings release (0001193125-26-344580) and the 10-Q periodic report (0001193125-26-344597) directly on SEC EDGAR. The filing index links above go to sec.gov.